Novartis Makes Room For OTC Division Head On Executive Committee
This article was originally published in The Tan Sheet
Novartis gives its OTC unit a direct line to the chief executive in an organizational realignment designed to strengthen and streamline the consumer businesses.
You may also be interested in...
Novartis will create an eye care division, its second-largest unit and the fifth growth platform in its health care portfolio, with full ownership of Alcon, the world's largest eye care company.
Novartis expedites a Triaminic line extension to take advantage of the branded product gap left by the recall of Johnson & Johnson's Children's Tylenol liquid OTCs
Incoming Novartis CEO Joe Jimenez plans to expand the Swiss firm's consumer health division over the next few years after he takes the reins from his predecessor Daniel Vasella